secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mereo BioPharma Group plc (MREO)
CIK:        0001719714
Form:       8-K
Filed at:   2026-08-19T11:52:29+00:00
Accession:  0001193125-26-356168
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Mereo BioPharma gets second Nasdaq notice; extra 180 days to meet $1 bid price
------------------------------------------------------------------------------

- Received second Nasdaq notice on Aug 18, 2026; new compliance deadline Feb 16, 2027.
- Must close at $1.00+ for 10 consecutive business days to regain compliance.
- If not compliant by Feb 16, 2027, Nasdaq will issue delisting notice; company may appeal.
- First notice received Feb 17, 2026; initial 180-day period expired Aug 17, 2026.
- Company monitoring bid price and considering options to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719714/000119312526356168/0001193125-26-356168-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719714/000119312526356168/mreo-20260217.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-356168

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer